Form 4: Sana Biotechnology Officer Reports Stock Transactions
SEC Form 4
Susan D. Wyrick, Acting CFO and Principal Accounting Officer of Sana Biotechnology, reports the vesting and subsequent tax withholding of restricted stock units.
Summary
- On March 2, 2025, Susan D. Wyrick, Acting Chief Financial Officer and Principal Accounting Officer of Sana Biotechnology, Inc., had 1,525 restricted stock units vest, which converted into common stock.
- Following the vesting, 490 shares were withheld on March 3, 2025, to cover tax obligations at a price of $2.56 per share.
- After these transactions, Wyrick directly owns 154,981 shares of Sana Biotechnology common stock and 3,050 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions, reflecting standard compensation practices. It doesn't inherently indicate positive or negative sentiment.
Future Outlook
The remaining restricted stock units vest in two equal installments on March 2, 2026, and March 2, 2027, contingent upon continued service to Sana Biotechnology.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the trading activities of company officers.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/02/2024 | 25% of the restricted stock units vested. |
| 03/02/2025 | 1,525 restricted stock units vested and converted to common stock. |
| 03/03/2025 | 490 shares were disposed of for tax obligations at $2.56 per share. |
| 03/02/2026 | Remaining restricted stock units vest in two equal installments. |
| 03/02/2027 | Remaining restricted stock units vest in two equal installments. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.